
Preterm infant with drug-resistant seizures responds to antisense oligonucleotide treatment
Ludwig-Maximilians-Universität München-led researchers have induced a greater than 60% reduction in seizure frequency in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy (DEE). Seizures initially occurred at a rate of 20 …